Latest Insider Transactions at Fate Therapeutics Inc (FATE)
This section provides a real-time view of insider transactions for Fate Therapeutics Inc (FATE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of FATE THERAPEUTICS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of FATE THERAPEUTICS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 16
2020
|
Cindy Tahl |
SELL
Open market or private sale
|
Direct |
29,199
-22.68%
|
$1,459,950
$50.25 P/Share
|
|
Oct 16
2020
|
Cindy Tahl |
BUY
Exercise of conversion of derivative security
|
Direct |
29,199
+18.49%
|
$58,398
$2.73 P/Share
|
|
Oct 01
2020
|
Cindy Tahl |
SELL
Open market or private sale
|
Direct |
35,000
-9.43%
|
$1,435,000
$41.1 P/Share
|
|
Oct 01
2020
|
Cindy Tahl |
BUY
Exercise of conversion of derivative security
|
Direct |
35,000
+20.65%
|
$70,000
$2.73 P/Share
|
|
Jun 11
2020
|
Redmile Group, LLC Director |
BUY
Open market or private purchase
|
Indirect |
1,412,928
+10.06%
|
$39,561,984
$28.31 P/Share
|
|
Sep 16
2019
|
Redmile Group, LLC Director |
BUY
Open market or private purchase
|
Indirect |
857,143
+7.1%
|
$14,571,431
$17.5 P/Share
|
|
Sep 25
2018
|
Redmile Group, LLC Director |
BUY
Open market or private purchase
|
Indirect |
3,703,704
+26.34%
|
$48,148,152
$13.5 P/Share
|